Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance

Simons, J M; Maaskant-Braat, A J G; Luiten, E J T; Leidenius, M H; van Nijnatten, T J A; Boelens, P G; Koppert, L B; van der Pol, C C; van de Velde, C J H; Audisio, R A; Smidt, M L

doi:https://doi.org/10.1016/j.ejso.2019.10.022

Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance

DSpace/Manakin Repository

Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance

Simons, J M; Maaskant-Braat, A J G; Luiten, E J T; Leidenius, M H; van Nijnatten, T J A; Boelens, P G; Koppert, L B; van der Pol, C C; van de Velde, C J H; Audisio, R A; Smidt, M L

(2020) European Journal of Surgical Oncology, volume 46, issue 1, pp. 218 - 219

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Axilla, Humans, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy, Specialization, Surveys and Questionnaires, Axillary staging, Node-positive, Breast cancer, Treatment-response, Axillary lymph node dissection, Neoadjuvant systemic therapy, Oncology, Surgery, Comment, Letter

DOI: https://doi.org/10.1016/j.ejso.2019.10.022

ISSN: 0748-7983

Publisher: W.B. Saunders Ltd

(Peer reviewed)